These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 133588)

  • 21. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Confounding factors in HLA-DW 2 typing of human leucocytes.
    Källén B; Löw B; Nilsson O
    Clin Exp Immunol; 1977 Jan; 27(1):55-62. PubMed ID: 139221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated T lymphocytes in patients with multiple sclerosis.
    Golaz J; Steck A; Moretta L
    Neurology; 1983 Oct; 33(10):1371-3. PubMed ID: 6193457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of active E-rosette forming lymphocytes by myelin basic protein and specific antigens from multiple sclerosis brains.
    Offner H; Rastogi SC; Konat G; Clausen J
    J Neurol Sci; 1979 Aug; 42(3):349-55. PubMed ID: 92529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.
    Huang YM; Stoyanova N; Jin YP; Teleshova N; Hussien Y; Xiao BG; Fredrikson S; Link H
    Clin Exp Immunol; 2001 May; 124(2):306-14. PubMed ID: 11422209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of regulatory cells in spinal fluid and blood in patients with multiple sclerosis and other neurologic diseases.
    Birnbaum G; Lackovic V; Kotilinek L; Tobolt D
    Neurology; 1990 Nov; 40(11):1785-90. PubMed ID: 1978261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte subpopulations in the cerebrospinal fluid and peripheral blood in multiple sclerosis.
    Członkowska A; Półtorak M; Cendrowski W; Korlak J
    Acta Neurol Scand; 1980 Jul; 62(1):55-62. PubMed ID: 6971037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.
    Rossi GA; Zocchi E; Sacco O; Balbi B; Ravazzoni C; Damiani G
    Am Rev Respir Dis; 1986 Jan; 133(1):78-82. PubMed ID: 2935058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests.
    Shenton BK; Jenssen HL; Werner H; Field EJ
    J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.
    Birnbaum G; Kotilinek L; Schwartz M; Sternad M
    J Clin Invest; 1984 Oct; 74(4):1307-17. PubMed ID: 6237121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics.
    Carnegie PR; Caspary EA; Dickinson JP; Field EJ
    Clin Exp Immunol; 1973 May; 14(1):37-45. PubMed ID: 4716103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
    Denbow CJ; Conroy JM; Elgert KD
    Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in multiple sclerosis.
    Manconi PE; Marrosu MG; Cianchetti C; Ennas MG; Mangoni A; Zaccheo D
    Acta Neurol Scand; 1980 Sep; 62(3):165-75. PubMed ID: 6971039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed leukocyte reaction (MLR) in arthritides.
    Hedberg H; Källén B; Löw B; Nilsson O
    Rheumatology; 1975; 6():90-7. PubMed ID: 128113
    [No Abstract]   [Full Text] [Related]  

  • 35. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.
    Jersild C; Fog T; Hansen GS; Thomsen M; Svejgaard A; Dupont B
    Lancet; 1973 Dec; 2(7840):1221-5. PubMed ID: 4128558
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients.
    Imamura K; Suzumura A; Hayashi F; Marunouchi T
    Acta Neurol Scand; 1993 Apr; 87(4):281-5. PubMed ID: 8503256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-specificity of laboratory test for diagnosis of multiple sclerosis.
    Mertin J; Hughes D; Caspary EA; Thomson AM; Foster JB; Stewart-Wynne EG
    Br Med J; 1974 Dec; 4(5944):567-9. PubMed ID: 4434141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole blood assay for assessment of the mixed lymphocyte reaction.
    Bromelow KV; Hirst W; Mendes RL; Winkley AR; Smith IE; O'Brien ME; Souberbielle BE
    J Immunol Methods; 2001 Jan; 247(1-2):1-8. PubMed ID: 11150531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitization of cerebrospinal fluid and peripheral blood lymphocytes to myelin basic protein in multiple sclerosis.
    Członkowska A; Półtorak M; Cendrowski W; Korlak J
    Acta Neurol Scand; 1982 Jul; 66(1):121-9. PubMed ID: 6180592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte sensitization to basic protein of brain in multiple sclerosis and other neurological diseases.
    Caspary EA; Field EJ
    J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):701-3. PubMed ID: 4135820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.